Skip to Content These are not all the possible side effects of Celexa.
Peripheral neuropathy has been observed in patients treated with Fludarabine phosphate and one case of wrist-drop was reported. A patient Medication Guide about “Antidepressant Medicines, Depression and other Serious Mental Illness, and Suicidal Thoughts or Actions” is available for Celexa. One patient developed a pericardial effusion possibly related to treatment with Fludarabine phosphate.
During a 5-day treatment schedule, 2-fluoroara-A plasma trough levels increased by a factor of about 2. Fludarabine phosphate was embryolethal and teratogenic in rats and rabbits. These episodes have occurred both in previously treated or untreated patients.Instances of life-threatening and sometimes fatal autoimmune phenomena such as hemolytic anemia, autoimmune thrombocytopenia/thrombocytopenic purpura (ITP), Evans syndrome, and acquired hemophilia have been reported to occur after one or more cycles of treatment with Fludarabine phosphate in patients with or without a previous history of autoimmune hemolytic anemia or a positive Coombs' test and who may or may not be in remission from their disease. The spectrum of adverse effects reported in these studies was consistent with the data presented above.The use of Fludarabine Phosphate Injection in combination with pentostatin is not recommended due to the risk of fatal pulmonary toxicity Based on its mechanism of action, Fludarabine phosphate can cause fetal harm when administered to a pregnant woman. You may ask your healthcare provider or pharmacist for information about Celexa that is written for healthcare professionals.For more information about Celexa call 1-800-678-1605 or go to www.Celexa.com.This Medication Guide has been approved by the U.S. Food and Drug Administration.The easiest way to lookup drug information, identify pills, check interactions and set up your own personal medication records. In one study, patients were assigned randomly to placebo or to the same dose of Celexa (20-60 mg/day) during maintenance treatment as they had received during the acute stabilization phase, while in the other study, patients were assigned randomly to continuation of Celexa 20 or 40 mg/day, or placebo, for maintenance treatment. Signs and symptoms associated with more severe and/or acute cases have included hallucination, syncope, seizure, coma, respiratory arrest, and death.In placebo-controlled trials of Celexa, some of which included patients with bipolar disorder, activation of mania/hypomania was reported in 0.2% of 1063 patients treated with Celexa and in none of the 446 patients treated with placebo.
You may report side effects to Health Canada at 1-866-234-2345.Before using this medication, tell your doctor or pharmacist your medical history, especially of: current infections, certain infections (To lower your chance of getting cut, bruised, or injured, use caution with sharp objects like razors and nail cutters, and avoid activities such as contact sports.Kidney function declines as you grow older. Ineffectivecoping(Indications) Riskforinjury(SideEffects) Sexualdysfunction(SideEffects) Implementation FLUDARA FOR INJECTION is indicated for the treatment of adult patients with B-cell chronic . Peripheral neuropathy has been observed in patients treated with Fludarabine phosphate and one case of wrist-drop was reported. Case reports and epidemiological studies (case-control and cohort design) have demonstrated an association between use of drugs that interfere with serotonin reuptake and the occurrence of gastrointestinal bleeding. These episodes have occurred both in previously treated or untreated patients.Life-threatening and sometimes fatal autoimmune phenomena such as hemolytic anemias, autoimmune thrombocytopenia/thrombocytopenic purpura (ITP), Evans syndrome, and acquired hemophilia have been reported to occur in patients receiving Fludarabine phosphate In post-marketing experience, cases of myelodysplastic syndrome and acute myeloid leukemia, mainly associated with prior, concomitant or subsequent treatment with alkylating agents, topoisomerase inhibitors, or irradiation have been reported.Serious and sometimes fatal infections, including opportunistic infections and reactivations of latent viral infections such as VZV (herpes zoster), Epstein-Barr virus and JC virus (progressive multifocal leukoencephalopathy) have been reported in patients treated with Fludarabine phosphate.Rare cases of Epstein-Barr (EBV) associated lymphoproliferative disorders have been reported in patients treated with Fludarabine phosphate.In post-marketing experience, cases of progressive multifocal leukoencephalopathy have been reported. The mechanism of action of this antimetabolite is not completely characterized and may be multi-faceted.Phase I studies in humans have demonstrated that Fludarabine phosphate is rapidly converted to the active metabolite, 2-fluoro-ara-A, within minutes after intravenous infusion. Available for Android and iOS devices.
The conditions and duration of treatment with Celexa varied greatly and included (in overlapping categories) open-label and double-blind studies, inpatient and outpatient studies, fixed-dose and dose-titration studies, and short-term and long-term exposure. To lower your risk of serious side effects, your doctor will follow your condition closely and order lab tests.Tell your doctor right away if any of these unlikely but serious side effects occur: fast/irregular heartbeat, swelling Fludarabine sometimes causes side effects due to the rapid destruction of Seek immediate medical attention if any of these rare but very serious side effects occur: bloody/black/tarry stool, persistent This is not a complete list of possible side effects. Depression and certain other psychiatric disorders are themselves associated with increases in the risk of suicide.